CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 106 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,945,000 | +18.5% | 61,404 | +4.9% | 0.00% | 0.0% |
| Q1 2017 | $5,863,000 | +2.0% | 58,559 | +9.5% | 0.00% | 0.0% |
| Q4 2016 | $5,749,000 | -67.0% | 53,468 | -61.8% | 0.00% | -60.0% |
| Q3 2016 | $17,435,000 | +340.1% | 140,066 | +275.9% | 0.01% | +400.0% |
| Q2 2016 | $3,962,000 | +53.5% | 37,262 | +65.3% | 0.00% | 0.0% |
| Q1 2016 | $2,581,000 | +56.1% | 22,540 | +94.2% | 0.00% | 0.0% |
| Q4 2015 | $1,653,000 | +137.8% | 11,605 | +92.3% | 0.00% | – |
| Q2 2015 | $695,000 | +20.5% | 6,035 | -0.1% | 0.00% | – |
| Q1 2015 | $577,000 | – | 6,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
| RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
| Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
| OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
| Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
| Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
| Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
| Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
| Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |